Analyst Rating In Review: GlaxoSmithKline Sold Off 0.6% Since Upgraded 7 Days Ago (GSK)
July 22, 2016 at 01:03 AM EDT
A week ago, Jefferies upgraded GlaxoSmithKline from Hold to Buy. GlaxoSmithKline stocks closed at $43.60, a 0.6% loss over the course of one week.There is potential upside of 8.4%...
